Zobrazeno 1 - 10
of 32
pro vyhledávání: '"HIROO TOMINAGA"'
Autor:
Tatsuro Jo, Takahiro Sakai, Kaori Matsuzaka, Haruna Shioya, Hiroo Tominaga, Yohei Kaneko, Shizuka Hayashi, Masatoshi Matsuo, Jun Taguchi, Kuniko Abe, Kazuto Shigematsu
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1402-1409 (2020)
We present the case of a 78-year-old male patient who was diagnosed with anaplastic lymphoma kinase (ALK)-negative, CC chemokine receptor 4 (CCR4)-negative, and CD30-positive anaplastic large cell lymphoma (ALCL). The patient had a past medical histo
Externí odkaz:
https://doaj.org/article/439ff71130c943c8a3352fa45a5d1b48
Autor:
Tatsuro Jo, Haruna Shioya, Hiroo Tominaga, Takahiro Sakai, Shizuka Hayashi, Kaori Matsuzaka, Yohei Kaneko, Masatoshi Matsuo, Jun Taguchi
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 990-996 (2020)
This case report is about a patient who suffered from Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia. The blasts were positive for myeloid-lineage markers including CD13 and CD33, as well as B-cell-lineage markers. Minor bcr-abl1
Externí odkaz:
https://doaj.org/article/a6ab89a3230841d184f80b6bced60b23
Autor:
Haruna Shioya, Hiroo Tominaga, Kuniko Abe, Kazuto Shigematsu, Tatsuro Jo, Takahiro Sakai, Kaori Matsuzaka, Yohei Kaneko, Shizuka Hayashi, Jun Taguchi, Masatoshi Matsuo
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 3, Pp 1402-1409 (2020)
Case Reports in Oncology, Vol 13, Iss 3, Pp 1402-1409 (2020)
We present the case of a 78-year-old male patient who was diagnosed with anaplastic lymphoma kinase (ALK)-negative, CC chemokine receptor 4 (CCR4)-negative, and CD30-positive anaplastic large cell lymphoma (ALCL). The patient had a past medical histo
Autor:
Masatoshi Matsuo, Tatsuro Jo, Kuniko Abe, Jun Taguchi, Hiroo Tominaga, Ritsuko Kubota-Koketsu, Yohei Kaneko, Shizuka Hayashi, Kazuto Shigematsu, Takahiro Sakai, Kaori Matsuzaka, Haruna Shioya
Publikováno v:
Anticancer Research. 40:5237-5243
Background/aim Adult T-cell leukemia/lymphoma (ATLL) is a relatively refractory CD4-positive peripheral T-cell lymphoma. VCAP-AMP-VECP (mLSG15) is one of the standard chemotherapeutic regimens for patients with aggressive ATLL. Mogamulizumab (moga),
Autor:
Hiroo Tominaga, Yohei Kaneko, Shizuka Hayashi, Haruna Shioya, Takahiro Sakai, Masatoshi Matsuo, Tatsuro Jo, Jun Taguchi, Kaori Matsuzaka
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 13, Iss 2, Pp 990-996 (2020)
Case Reports in Oncology, Vol 13, Iss 2, Pp 990-996 (2020)
This case report is about a patient who suffered from Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia. The blasts were positive for myeloid-lineage markers including CD13 and CD33, as well as B-cell-lineage markers. Minor bcr-abl1
Autor:
Kazuto Shigematsu, Hiroo Tominaga, Yohei Kaneko, Shizuka Hayashi, Takahiro Sakai, Kaori Matsuzaka, Masatoshi Matsuo, Tatsuro Jo, Haruna Shioya, Jun Taguchi
Publikováno v:
Blood. 134:4048-4048
Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a rare and quite refractory peripheral T-cell lymphoma. The human T-lymphotropic virus type 1 (HTLV-1) retrovirus causes ATLL. Tax protein produced by HTLV-1 has oncogenic activities, and its pep
Autor:
Norihito Kaku, Tsuyoshi Sato, Munetoshi Nakashima, Seiji Nagashima, Minoru Fukuda, Kohji Hashiguchi, Katsunori Yanagihara, Yoshitomo Morinaga, Shigeru Kohno, Takahiro Sakai, Hiroo Tominaga, Fumiko Wakigawa
Publikováno v:
Journal of Infection and Chemotherapy. 19:166-170
A 65-year-old man was admitted to our hospital with a temperature of 39.3 C, cough, sputum, and pharyngeal discomfort that had persisted for 3 days. He had been treated with methotrexate and adalimumab (a tumor necrosis factor-alpha [TNF-α] inhibito
Autor:
Hiroo Tominaga
Publikováno v:
TRENDS IN THE SCIENCES. 2:86-89
Publikováno v:
NIPPON KAGAKU KAISHI. :919-924
Autor:
Hiroo Tominaga
Publikováno v:
Journal of the Fuel Society of Japan. 53:631-639
Oil sands resources in Athabasca, Canada, and Orinoco oil belt, Venezuela, have been investigated. Their magnitude as bitumen in place is roughly comparable to that of conventional crude oil. The present proven technologies and some future technical